Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery
Alexis Leonard(St. Jude Children's Research Hospital), John F. Tisdale(National Heart Lung and Blood Institute), Aylin Bonifacino(National Institutes of Health), Selami Demirci(National Institutes of Health), Francis J. Pierciey(Somerville Hospital), Naoya Uchida(National Heart Lung and Blood Institute), Juan J. Haro‐Mora(National Institutes of Health), Venina Marcela Dominical(National Institutes of Health), Min Luo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 75
Related Papers
Antimicrobial Properties of Zeolite-X and Zeolite-A Ion-Exchanged with Silver, Copper, and Zinc Against a Broad Range of Microorganisms
|Applied Biochemistry and Biotechnology|2013|173
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2024|119
Boron and Poloxamer (F68 and F127) Containing Hydrogel Formulation for Burn Wound Healing
|Biological Trace Element Research|2015|114
Gene therapy for sickle cell disease: An update
|Cytotherapy|2018|114
NuRD Blocks Reprogramming of Mouse Somatic Cells into Pluripotent Stem Cells
|Stem Cells|2013|104